SEC Form 4 · accession 0001628280-18-011318
Fibrocell Science, Inc. · FCSC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Michael Maslowski
Officer — CEO · Director
Period of report
Aug 22, 2018
Accepted (ET)
Aug 23, 2018 · 12:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000357097
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 22, 2018 | P | 3,000 | $2.0624 | A | 3,164 | D |
Table II — derivative securities
No Table II lines on this filing.